Merck & Co
Merck posted a net fourth-quarter profit of $1.51 billion, or 49 cents per share, compared with a loss of $531 million, or 17 cents a share, a year ago, when the company took a $1.7 billion charge related to a major clinical setback.
Excluding items, including acquisition and restructuring expenses, Merck earned 97 cents per share. Analysts on average expected 95 cents per share, according to Thomson Reuters I/B/E/S.
Global revenue rose 2 percent to $12.29 billion, just shy of Wall Street expectations of $12.53 billion.
(Reporting By Ransdell Pierson; Editing by Maureen Bavdek)